Differentiated phenotypes of primary murine alveolar epithelial cells and their susceptibility to infection by respiratory viruses

Virus Research

Volumn 175, Issue 2, 2013, Pages 110-119

  Kebaabetswe, Lemme P ^a   Haick, Anoria K ^a   Miura, Tanya A ^a  

^a UNIVERSITY OF IDAHO   (United States)

Author keywords

Alveolar epithelial cells; Cytokines; Influenza A virus; Mouse adapted SARS coronavirus; Murine coronavirus; Type I pneumocyte; Type II pneumocyte

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CXCL1 CHEMOKINE; CXCL13 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 16; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; PROTEIN BCL 6; VIRUS ANTIGEN;

ANIMAL CELL; ANTIGEN DETECTION; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CORONAVIRUS; CORONAVIRUS MHV 1; CYTOKINE RESPONSE; DISEASE PREDISPOSITION; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; INFLUENZA VIRUS A H1N1; LUNG ALVEOLUS EPITHELIUM; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS REPLICATION;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MICE; MICE, INBRED C57BL; MURINE HEPATITIS VIRUS; PHENOTYPE; SARS VIRUS; VIRAL TROPISM;

CORONAVIRUS; INFLUENZA A VIRUS; MACROPODID HERPESVIRUS 1; MURINAE; MURINE HEPATITIS VIRUS; SARS CORONAVIRUS;

EID: 84878848448     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2013.04.008     Document Type: Article

References (64)

1. Alberts R., Srivastava B., Wu H., Viegas N., Geffers R., Klawonn F., Novoselova N., do Valle T.Z., Panthier J.J., Schughart K. Gene expression changes in the host response between resistant and susceptible inbred mouse strains after influenza A infection. Microbes and Infection/Institut Pasteur 2010, 12(4):309-318.
2. Becker M.M., Graham R.L., Donaldson E.F., Rockx B., Sims A.C., Sheahan T., Pickles R.J., Corti D., Johnston R.E., Baric R.S., Denison M.R. Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(50):19944-19949.
3. Bello-Irizarry S.N., Wang J., Olsen K., Gigliotti F., Wright T.W. The alveolar epithelial cell chemokine response to pneumocystis requires adaptor molecule MyD88 and interleukin-1 receptor but not toll-like receptor 2 or 4. Infection and Immunity 2012, 80(11):3912-3920.
4. Blazejewska P., Koscinski L., Viegas N., Anhlan D., Ludwig S., Schughart K. Pathogenicity of different PR8 influenza A virus variants in mice is determined by both viral and host factors. Virology 2011, 412(1):36-45.
5. Corti M., Brody A.R., Harrison J.H. Isolation and primary culture of murine alveolar type II cells. American Journal of Respiratory Cell and Molecular Biology 1996, 14(4):309-315.
6. Day C.W., Baric R., Cai S.X., Frieman M., Kumaki Y., Morrey J.D., Smee D.F., Barnard D.L. A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo. Virology 2009, 395(2):210-222.
7. De Albuquerque N., Baig E., Ma X., Zhang J., He W., Rowe A., Habal M., Liu M., Shalev I., Downey G.P., Gorczynski R., Butany J., Leibowitz J., Weiss S.R., McGilvray I.D., Phillips M.J., Fish E.N., Levy G.A. Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice. Journal of Virology 2006, 80(21):10382-10394.
8. DeMaio L., Tseng W., Balverde Z., Alvarez J.R., Kim K.J., Kelley D.G., Senior R.M., Crandall E.D., Borok Z. Characterization of mouse alveolar epithelial cell monolayers. American Journal of Physiology: Lung Cellular and Molecular Physiology 2009, 296(6):L1051-L1058.
9. Dobbs L.G., Williams M.C., Gonzalez R. Monoclonal antibodies specific to apical surfaces of rat alveolar type I cells bind to surfaces of cultured, but not freshly isolated, type II cells. Biochimica et Biophysica Acta 1988, 970(2):146-156.
10. Frana M.F., Behnke J.N., Sturman L.S., Holmes K.V. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: host-dependent differences in proteolytic cleavage and cell fusion. Journal of Virology 1985, 56(3):912-920.
11. Frieman M., Yount B., Agnihothram S., Page C., Donaldson E., Roberts A., Vogel L., Woodruff B., Scorpio D., Subbarao K., Baric R.S. Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease. Journal of Virology 2012, 86(2):884-897.
12. Fukushi M., Ito T., Oka T., Kitazawa T., Miyoshi-Akiyama T., Kirikae T., Yamashita M., Kudo K. Serial histopathological examination of the lungs of mice infected with influenza A virus PR8 strain. PLoS ONE 2011, 6(6):e21207.
13. Funk C.J., Manzer R., Miura T.A., Groshong S.D., Ito Y., Travanty E.A., Leete J., Holmes K.V., Mason R.J. Rat respiratory coronavirus infection: replication in airway and alveolar epithelial cells and the innate immune response. Journal of General Virology 2009, 90(Pt 12):2956-2964.
14. Glowacka I., Bertram S., Muller M.A., Allen P., Soilleux E., Pfefferle S., Steffen I., Tsegaye T.S., He Y., Gnirss K., Niemeyer D., Schneider H., Drosten C., Pohlmann S. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. Journal of Virology 2011, 85(9):4122-4134.
15. Gonzalez R., Yang Y.H., Griffin C., Allen L., Tigue Z., Dobbs L. Freshly isolated rat alveolar type I cells, type II cells, and cultured type II cells have distinct molecular phenotypes. American Journal of Physiology: Lung Cellular and Molecular Physiology 2005, 288(1):L179-L189.
16. Herold S., Steinmueller M., von Wulffen W., Cakarova L., Pinto R., Pleschka S., Mack M., Kuziel W.A., Corazza N., Brunner T., Seeger W., Lohmeyer J. Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. Journal of Experimental Medicine 2008, 205(13):3065-3077.
17. Herold S., von Wulffen W., Steinmueller M., Pleschka S., Kuziel W.A., Mack M., Srivastava M., Seeger W., Maus U.A., Lohmeyer J. Alveolar epithelial cells direct monocyte transepithelial migration upon influenza virus infection: impact of chemokines and adhesion molecules. Journal of Immunology 2006, 177(3):1817-1824.
18. Hrincius E.R., Hennecke A.K., Gensler L., Nordhoff C., Anhlan D., Vogel P., McCullers J.A., Ludwig S., Ehrhardt C. A single point mutation (Y89F) within the non-structural protein 1 of influenza A viruses limits epithelial cell tropism and virulence in mice. American Journal of Pathology 2012, 180(6):2361-2374.
19. Johnson J.E., Gonzales R.A., Olson S.J., Wright P.F., Graham B.S. The histopathology of fatal untreated human respiratory syncytial virus infection. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology, Inc. 2007, 20(1):108-119.
20. Khanolkar A., Hartwig S.M., Haag B.A., Meyerholz D.K., Harty J.T., Varga S.M. Toll-like receptor 4 deficiency increases disease and mortality after mouse hepatitis virus type 1 infection of susceptible C3H mice. Journal of Virology 2009, 83(17):8946-8956.
21. Kim K.K., Kugler M.C., Wolters P.J., Robillard L., Galvez M.G., Brumwell A.N., Sheppard D., Chapman H.A. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(35):13180-13185.
22. Korteweg C., Gu J. Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. American Journal of Pathology 2008, 172(5):1155-1170.
23. Kosmider B., Messier E.M., Janssen W.J., Nahreini P., Wang J., Hartshorn K.L., Mason R.J. Nrf2 protects human alveolar epithelial cells against injury induced by influenza A virus. Respiratory Research 2012, 13(1):43.
24. Le Goffic R., Balloy V., Lagranderie M., Alexopoulou L., Escriou N., Flavell R., Chignard M., Si-Tahar M. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathogens 2006, 2(6):e53.
25. Leibowitz J.L., Srinivasa R., Williamson S.T., Chua M.M., Liu M., Wu S., Kang H., Ma X.Z., Zhang J., Shalev I., Smith R., Phillips M.J., Levy G.A., Weiss S.R. Genetic determinants of mouse hepatitis virus strain 1 pneumovirulence. Journal of Virology 2010, 84(18):9278-9291.
26. Li F. Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections. Journal of Virology 2008, 82(14):6984-6991.
27. Liem N.T., Nakajima N., Phat le P., Sato Y., Thach H.N., Hung P.V., San L.T., Katano H., Kumasaka T., Oka T., Kawachi S., Matsushita T., Sata T., Kudo K., Suzuki K. H5N1-infected cells in lung with diffuse alveolar damage in exudative phase from a fatal case in Vietnam. Japanese Journal of Infectious Diseases 2008, 61(2):157-160.
28. Loosli C.G., Stinson S.F., Ryan D.P., Hertweck M.S., Hardy J.D., Serebrin R. The destruction of type 2 pneumocytes by airborne influenza PR8-A virus; its effect on surfactant and lecithin content of the pneumonic lesions of mice. Chest 1975, 67(2 Suppl.):7S-14S.
29. Marsh L.M., Cakarova L., Kwapiszewska G., von Wulffen W., Herold S., Seeger W., Lohmeyer J. Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair. American Journal of Physiology: Lung Cellular and Molecular Physiology 2009, 296(3):L442-L452.
30. Mason R.J. Biology of alveolar type II cells. Respirology 2006, (11 Suppl.):S12-S15.
31. Mason R.J., Williams M.C. Phospholipid composition and ultrastructure of A549 cells and other cultured pulmonary epithelial cells of presumed type II cell origin. Biochimica et Biophysica Acta 1980, 617(1):36-50.
32. Matsuyama S., Nagata N., Shirato K., Kawase M., Takeda M., Taguchi F. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. Journal of Virology 2010, 84(24):12658-12664.
33. Mendez M.P., Morris S.B., Wilcoxen S., Greeson E., Moore B., Paine R. Shedding of soluble ICAM-1 into the alveolar space in murine models of acute lung injury. American Journal of Physiology: Lung Cellular and Molecular Physiology 2006, 290(5):L962-L970.
34. Messier E.M., Mason R.J., Kosmider B. Efficient and rapid isolation and purification of mouse alveolar type II epithelial cells. Experimental Lung Research 2012, 38(7):363-373.
35. Mir-Kasimov M., Sturrock A., McManus M., Paine R. Effect of alveolar epithelial cell plasticity on the regulation of GM-CSF expression. American Journal of Physiology: Lung Cellular and Molecular Physiology 2012, 302(6):L504-L511.
36. Miura T.A., Wang J., Holmes K.V., Mason R.J. Rat coronaviruses infect rat alveolar type I epithelial cells and induce expression of CXC chemokines. Virology 2007, 369(2):288-298.
37. Mossel E.C., Wang J., Jeffers S., Edeen K.E., Wang S., Cosgrove G.P., Funk C.J., Manzer R., Miura T.A., Pearson L.D., Holmes K.V., Mason R.J. SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells. Virology 2008, 372(1):127-135.
38. Mulugeta S., Gray J.M., Notarfrancesco K.L., Gonzales L.W., Koval M., Feinstein S.I., Ballard P.L., Fisher A.B., Shuman H. Identification of LBM180, a lamellar body limiting membrane protein of alveolar type II cells, as the ABC transporter protein ABCA3. Journal of Biological Chemistry 2002, 277(25):22147-22155.
39. Nakajima N., Van Tin N., Sato Y., Thach H.N., Katano H., Diep P.H., Kumasaka T., Thuy N.T., Hasegawa H., San L.T., Kawachi S., Liem N.T., Suzuki K., Sata T. Pathological study of archival lung tissues from five fatal cases of avian H5N1 influenza in Vietnam. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology, Inc. 2013, 26(3):357-369.
40. Nicholls J.M., Butany J., Poon L.L., Chan K.H., Beh S.L., Poutanen S., Peiris J.S., Wong M. Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. PLoS Medicine 2006, 3(2):e27.
41. Oh H.A., Park C.S., Ahn H.J., Park Y.S., Kim H.M. Effect of Perilla frutescens var. acuta Kudo and rosmarinic acid on allergic inflammatory reactions. Experimental Biology and Medicine (Maywood, NJ) 2011, 236(1):99-106.
42. Paine R., Joyce-Brady M., Clement A., Brody J.S. Serum accelerates the loss of type II cell differentiation in vitro. American Journal of Respiratory Cell and Molecular Biology 1990, 3(4):311-323.
43. Qiao R., Zhou B., Liebler J.M., Li X., Crandall E.D., Borok Z. Identification of three genes of known function expressed by alveolar epithelial type I cells. American Journal of Respiratory Cell and Molecular Biology 2003, 29(1):98-105.
44. Ramirez M.I., Millien G., Hinds A., Cao Y., Seldin D.C., Williams M.C. T1alpha, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth. Developmental Biology 2003, 256(1):61-72.
45. Raoust E.S., Balloy V., Garcia-Verdugo I., Touqui L., Ramphal R., Chignard M. Pseudomonas aeruginosa LPS or flagellin are sufficient to activate TLR-dependent signaling in murine alveolar macrophages and airway epithelial cells. PLoS ONE 2009, 4(10):e7259.
46. Rice W.R., Conkright J.J., Na C.-L., Ikegami M., Shannon J.M., Weaver T.E. Maintenance of the mouse type II cell phenotype in vitro. American Journal of Physiology: Lung Cellular and Molecular Physiology 2002, 283(2):L256-L264.
47. Roberts A., Deming D., Paddock C.D., Cheng A., Yount B., Vogel L., Herman B.D., Sheahan T., Heise M., Genrich G.L., Zaki S.R., Baric R., Subbarao K. A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice. PLoS Pathogens 2007, 3(1):e5.
48. Rzepka J.P., Haick A.K., Miura T.A. Virus-infected alveolar epithelial cells direct neutrophil chemotaxis and inhibit their apoptosis. American Journal of Respiratory Cell and Molecular Biology 2012, 46(6):833-841.
49. Sheahan T., Rockx B., Donaldson E., Sims A., Pickles R., Corti D., Baric R. Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium. Journal of Virology 2008, 82(5):2274-2285.
50. Shieh W.-J., Blau D.M., Denison A.M., DeLeon-Carnes M., Adem P., Bhatnagar J., Sumner J., Liu L., Patel M., Batten B., Greer P., Jones T., Smith C., Bartlett J., Montague J., White E., Rollin D., Gao R., Seales C., Jost H., Metcalfe M., Goldsmith C.S., Humphrey C., Schmitz A., Drew C., Paddock C., Uyeki T.M., Zaki S.R. 2009 Pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. American Journal of Pathology 2010, 177(1):166-175.
51. Shieh W.J., Hsiao C.H., Paddock C.D., Guarner J., Goldsmith C.S., Tatti K., Packard M., Mueller L., Wu M.Z., Rollin P., Su I.J., Zaki S.R. Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan. Human Pathology 2005, 36(3):303-309.
52. Shulla A., Heald-Sargent T., Subramanya G., Zhao J., Perlman S., Gallagher T. A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. Journal of Virology 2011, 85(2):873-882.
53. Srivastava B., Blazejewska P., Hessmann M., Bruder D., Geffers R., Mauel S., Gruber A.D., Schughart K. Host genetic background strongly influences the response to influenza A virus infections. PLoS ONE 2009, 4(3):e4857.
54. Sturman L.S., Holmes K.V., Behnke J. Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid. Journal of Virology 1980, 33(1):449-462.
55. Sturman L.S., Takemoto K.K. Enhanced growth of a murine coronavirus in transformed mouse cells. Infection and Immunity 1972, 6(4):501-507.
56. Swain R.J., Kemp S.J., Goldstraw P., Tetley T.D., Stevens M.M. Assessment of cell line models of primary human cells by Raman spectral phenotyping. Biophysical Journal 2010, 98(8):1703-1711.
57. Tate M.D., Schilter H.C., Brooks A.G., Reading P.C. Responses of mouse airway epithelial cells and alveolar macrophages to virulent and avirulent strains of influenza A virus. Viral Immunology 2011, 24(2):77-88.
58. Uiprasertkul M., Kitphati R., Puthavathana P., Kriwong R., Kongchanagul A., Ungchusak K., Angkasekwinai S., Chokephaibulkit K., Srisook K., Vanprapar N., Auewarakul P. Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans. Emerging Infectious Diseases 2007, 13(5):708-712.
59. Vlahos R., Stambas J., Bozinovski S., Broughton B.R., Drummond G.R., Selemidis S. Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation. PLoS Pathogens 2011, 7(2):e1001271.
60. Wang J., Nikrad M.P., Phang T., Gao B., Alford T., Ito Y., Edeen K., Travanty E.A., Kosmider B., Hartshorn K., Mason R.J. Innate immune response to influenza A virus in differentiated human alveolar type II cells. American Journal of Respiratory Cell and Molecular Biology 2011, 45(3):582-591.
61. Wang J., Oberley-Deegan R., Wang S., Nikrad M., Funk C.J., Hartshorn K.L., Mason R.J. Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection. Journal of Immunology 2009, 182(3):1296-1304.
62. Williams M.C. Alveolar type I cells: molecular phenotype and development. Annual Review of Physiology 2003, 65:669-695.
63. Yu W.C., Chan R.W., Wang J., Travanty E.A., Nicholls J.M., Peiris J.S., Mason R.J., Chan M.C. Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 viruses. Journal of Virology 2011, 85(14):6844-6855.
64. Zen K., Notarfrancesco K., Oorschot V., Slot J.W., Fisher A.B., Shuman H. Generation and characterization of monoclonal antibodies to alveolar type II cell lamellar body membrane. American Journal of Physiology 1998, 275(1 Pt 1):L172-L183.